Submitted Successfully!
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Ver. Summary Created by Modification Content Size Created at Operation
1 + 1674 word(s) 1674 2021-11-04 09:55:31 |
2 format correction Meta information modification 1674 2021-11-11 10:30:20 |

Video Upload Options

Do you have a full video?


Are you sure to Delete?
If you have any further questions, please contact Encyclopedia Editorial Office.
Sharifi-Rad, J. Signaling Pathways Involving Epigallocatechin Gallate. Encyclopedia. Available online: (accessed on 10 December 2023).
Sharifi-Rad J. Signaling Pathways Involving Epigallocatechin Gallate. Encyclopedia. Available at: Accessed December 10, 2023.
Sharifi-Rad, Javad. "Signaling Pathways Involving Epigallocatechin Gallate" Encyclopedia, (accessed December 10, 2023).
Sharifi-Rad, J.(2021, November 11). Signaling Pathways Involving Epigallocatechin Gallate. In Encyclopedia.
Sharifi-Rad, Javad. "Signaling Pathways Involving Epigallocatechin Gallate." Encyclopedia. Web. 11 November, 2021.
Signaling Pathways Involving Epigallocatechin Gallate

Epigallocatechin gallate (EGCG) is the main bioactive component of catechins predominantly present in various types of tea. EGCG is well known for a wide spectrum of biological activities as an anti-oxidative, anti-inflammatory, and anti-tumor agent. The effect of EGCG on cell death mechanisms via the induction of apoptosis, necrosis, and autophagy has been documented.

epigallocatechin-3-gallate EGCG catechin green tea cancer preventive pharmacological activities

1. Introduction

Tea has been known to be the world most renowned non-alcoholic beverage since ancient times and it is currently being utilized by two-thirds population of the world, owing to its taste, stimulating effects, unique aroma, and associated health perspectives [1][2]. Various types of tea like green, black and oolong tea are derived from the Camellia sinensis (L.) plant containing variety of components among which polyphenols are most significant ones. Basic differences among all of these teas depends upon the stage of fermentation processes from which they are produced. Purposely, green tea is not fermented while black tea and oolong tea are completely and partially fermented, respectively. Amongst all of the investigated teas around the globe, green tea is well studied, owing to its health promoting benefits. In general, tea based phenolics possess protective action against numerous metabolic syndromes.
Several nutraceutical aspects of green tea extracts depends upon the concentration of phenolics and their associated derivatives. The major biologically active moiety present in leaves of green tea are classified as catechins that nearly account for 25–35% on dry weight basis. This catechin group comprises eight phenolic flavonoid constituents, specifically, catechin, epicatechin, gallocatechin, epigallocatechin, catechin gallate, epicatechin gallate, gallocatechin gallate, and epigallocatechin gallate (EGCG) [3][4]. Among above mentioned polyphenols, EGCG is the most vital tea based catechin which is considered to be the main reason for bioactivity of green tea [5][6][7][8].
Catechins are plant secondary metabolites [9][10]. They possess numerous functions in plant survival, growth, and metabolism, but they can also interact with other living organisms if ingested or came into direct contact. Catechins or flavanols probably constitute the most abundant subclass of flavonoids and they are essentially represented by (–)-epigallocatechin-3-gallate (EGCG), (–)-epigallocatechin (EGC), (–)-epicatechin-3-gallate (ECG), and (–)-epicatechin (EC) [11]. These last four bioactive compounds are found in large amount in green tea (leaves of Camellia sinensis) and cocoa/chocolate, but they are also present in many fruits or seeds, such apples, blueberries (Vaccinium myrtillus) and grapes (red wine and beer) and peanuts [12]. This review focuses on catechins that are derived from green tea and in particular on EGCG, which represents 50% to 80% of all Camellia sinensis catechins (200–300 mg/brewed cup of green tea) [13]. Moreover, we analyzed preclinical works examining its pharmacological and biomolecular mechanism of action.
Epigallocatechin gallate is the most bioactive catechin that is predominantly present in tea. Among all of the tea types, it is found at maximum comncentration in green tea leaves. EGCG molecule (Figure 1) comprises two aromatic structures that are co-joined by three carbon bridge structure (C6-C3-C6) along with hydroxyl group (OH) at simultaneous carbons i.e., 3’, 4’, 5’ of ring-B. Carbon-3 of ring-C is esterified with a gallate molecule (features of catechins originated from tea are responsible for bioactivity due to position and number of OH-group on the rings. They regulate their capability to interact with biological matter via hydrogen bonding, a hydrogen and electron transferring process contained by their antioxidative potentials. The presence and absence of a galloyl molecule differentiates EGCG from remaining three catechins [14].
Figure 1. Chemical structure of epigallocatechin gallate.
Pure epigallocatechin gallate is classified as an odourless crystal and/or powder available in white, pink, or cream colour. It is considered to be soluble in water as a colorless and clear solution (5 mg mL−1). It is also soluble in methanol, tetrahydrofuran, acetone, pyridine, and ethanol. EGCG have a melting point at 218 °C [15].
Even though EGCG is found to be the most predominant and bioactive constituent present in tea, it is considered to be poorly stable in aqueous solutions and poorly soluble in oils and fats [16][17][18][19]. This poor stability and solubility restricts its direct addition in food products. Numerous delivery systems are, in practice, to preserve its structural integrity and shield EGCG from degradation [18][20][21][22][23][24]. Additionally, structural modification in EGCG has also aided in elevating its lipophilicity [25][26].
Numerous physical aspects like pH, light, oxidants contents, oxygen, temperature, and concentration of EGCG, influence the stability of epigallocatechin gallate [17][26][27][28][29]. Epimerization and auto-oxidation are two most important reactions that result in instability of EGCG and loss of its health promoting properties [30]. EGCG is oxidized at low concentration and temperature i.e., 20 to 100 μM & < 44 °C, respectively. On the other hand, it is epimerized to gallocatechin gallate at elevated temperature (greater than 44 °C) and acidic conditions (pH 2 to 5.5) [30][31][32][33]. EGCG at a concentration of 300 mg per litre has been found to be stable at 25 °C (24 h) in a pH range of 3 to 6, nonetheless if kept at 4 °C & 25 °C for 24 h (pH 7), a loss of 25 & 83%, respectively, was observed [29].
EGCG is an abundant source of phenolic OH-groups that leads to its health escalating properties. Various scientific studies (in vivo and in vitro) have been carried out to authenticate the potential of EGCG as an anti-oxidative, antiinflammatory, and anti-cancerous agent [34][35].
Wei and co-authors have reported that EGCG exerts an anti-tumor effect through the inhibition of key enzymes that participate in the glycolytic pathway and the suppression of glucose metabolism [36]. Shang and coworkers proposed that tea catechins in combination with anticancer drugs are being evaluated as a new cancer treatment strategy [37]. It has a potential role as adjuvant in cancer therapy and it could enhance the effect of conventional cancer therapies through additive or synergistic effects, as well as through the amelioration of deleterious side effects [38]. EGCG interacts with catalase and highlighted as an anticancer drug [39]. Green tea polyphenols are reported as a translational perspective of chemoprevention and treatment for cancer with concrete influence on signaling pathways [2]. EGCG as a powerful antioxidant, antiangiogenic, and antitumor agent, and as a modulator of tumor cell has the potential to impact in variety of human diseases [40].

2. Occurrence of Epigallocatechin-3-Gallate in Different Foods

The close relationship between food and disease is well known [41], thus EGCG consumed in food could be a natural potential source of health benefits, even in complex and intricated disorder as cancer.
Principal catechin in tea is EGCG, which is also known to be responsible for various health modulating perspectives tht are related to utilization of tea. According to Wu et al., (2012), a cup of green tea prepared by adding 2500 mg leaves in 0.2 L of water contains 90 mg of EGCG [42]. The content of EGCG in black tea is less when compared to green tea, mainly due to polymerization of catechins [43]. EGCG that are derived from tea possess various bioactive properties and, therefore, have attained attention as potent functional and nutraceutical ingredient in food and pharmaceutical industry. Table 1 lists EGCG contents in some selected foods.
Table 1. Occurrence of epigallocatechin-3-gallate in different food.




Japanese green tea

18.1–23.1 mg/g


Long-jing tea

32.9–35.5 mg/g

Jasmine tea

29.8–31.0 mg/g

Pu-erh tea

16.9–19.19.1 mg/g

Iron Buddha tea

0.12–0.30 mg/g

Oolong tea

11.8–12.2 mg/g

Ceylon tea

7.4–8.9 mg/g

Green tea

4.62 mg/100 mL


Black tea

1.35 mg/100 mL

Ban-cha (tea leaves)

12.2–27.3 mg/g DM


Fukamushi-cha (tea leaves)

13.8–18.6 mg/g DM

Yame-cha (tea leaves)

19.7–32.9 mg/g DM

Uji-cha tea leaves)

22.2–35.9 mg/g DM

Sayama-cha (tea leaves)

21.5–37.2 mg/g DM

Uji-matt-cha (Powder tea)

20.1–29.6 mg/g DM

Gyokuro-cha (Powder tea)

29.9–37.2 mg/g DM

Sen-cha (tea bags)

12.9–23.6 mg/g DM

Green tea (Bagged leave form)

54.3–153.0 mg/g dry tea


Green tea (Loose leave form)

56.5–205.0 mg/g dry tea

White tea (Bagged leave form)

46.0–154.0 mg/g dry tea

White tea (Loose leave form)

38.9–144.0 mg/g dry tea

Green tea (Infusions)

117 to 442 mg/l



7.9 mg/230 mL (mg/serving)


Tesco standard blend,

4.7 mg/230 mL (mg/serving)

Tesco premium blend,

5.6 mg/230 mL (mg/serving)

Sainsbury red blend,

8.5 mg/230 mL (mg/serving)

Sainsbury gold blend,

11.8 mg/230 mL (mg/serving)

PG Tips,

7.1 mg/230 mL (mg/serving)


5.7 mg/230 mL (mg/serving)

Apples, Fuji, raw, with skin

1.93 mg/100 g edible portion


Apples, Golden Delicious, raw, with skin

0.19 mg/100 g edible portion

Apples, Granny Smith, raw, with skin

0.24 mg/100 g edible portion

Apples, Red Delicious, raw, without skin

0.46 mg/100 g edible portion

Apples, Red Delicious, raw. with skin

0.13 mg/100 g edible portion

Avocados, raw,

0.15 mg/100 g edible portion

Blackberries, raw (Rubus spp.)

0.68 mg/100 g edible portion

Cranberries, raw

0.97 mg/100 g edible portion

Peaches, raw

0.30 mg/100 g edible portion

Pears, raw

0.17 mg/100 g edible portion

Plums, black diamond, with peel, raw

0.48 mg/100 g edible portion

Raspberries, raw

0.54 mg/100 g edible portion

Nuts, hazelnuts or filberts

1.06 mg/100 g edible portion

Nuts, pecans

2.30 mg/100 g edible portion

Nuts, pistachio nuts, raw

0.40 mg/100 g edible portion

Tea, black, brewed, prepared with tap water

9.36 mg/100 g edible portion

Tea, black, brewed, prepared with tap water, decaffeinated

1.01 mg/100 g edible portion

Tea, fruit, dry

415.0 mg/100 g edible portion

Tea, green, brewed

64.0 mg/100 g edible portion

Tea, green, brewed, decaffeinated

26.0 mg/100 g edible portion

Tea, green, large leaf, Quingmao, dry leaves

7380 mg/100 g edible portion

Tea, oolong, brewed

34.48 mg/100 g edible portion

Tea, white, brewed

46.0 mg/100 g edible portion

Tea, white, dry leaves

4245 mg/100 g edible portion

Carob flour

109.46 mg/100 g edible portion

3. Signaling Pathways Involving EGCG: Proliferation, Differentiation, Apoptosis, Inflammation, Angiogenesis and Metastasis

A plethora of biomolecular mechanisms has been demonstrated and proposed to be involved in the use of this catechin in preclinical models. These can include, but are not limited to, the induction of apoptosis, cell cycle change, antioxidant activity, modulation of drug metabolism enzymes, etc. EGCG possesses multiple pharmacological activities, depending on cancer cell type, thus reflecting different protein expression and epigenetic mechanisms. Every cell model can express and modulate at convenience its genetic background, and this is at the basis of the diverse biomolecular targets triggered by EGCG. More consistently, EGCG has been analyzed in different tumor cell lines and less frequently in animal models: this paragraph investigates the association of EGCG with proliferation, differentiation, apoptosis, inflammation, angiogenesis, and metastasis, i.e., the main signaling pathways and processes of living cells (Figure 2).
Figure 2. Epigallocatechin gallate (EGCG) involved in the signaling pathways in cancer.


  1. Gupta, S.; Saha, B.; Giri, A.K. Comparative antimutagenic and anticlastogenic effects of green tea and black tea: A review. Mutat. Res. Rev. Mutat. Res. 2002, 512, 37–65.
  2. Hu, G.; Zhang, L.; Rong, Y.; Ni, X.; Sun, Y. Downstream carcinogenesis signaling pathways by green tea polyphenols: A translational perspective of chemoprevention and treatment for cancers. Curr. Drug Metab. 2014, 15, 14–22.
  3. Sang, S.; Lambert, J.D.; Ho, C.-T.; Yang, C.S. The chemistry and biotransformation of tea constituents. Pharmacol. Res. 2011, 64, 87–99.
  4. Min, K.; Kwon, T.K. Anticancer effects and molecular mechanisms of epigallocatechin-3-gallate. Integr. Med. Res. 2014, 3, 16–24.
  5. Nagle, D.G.; Ferreira, D.; Zhou, Y.-D. Epigallocatechin-3-gallate (EGCG): Chemical and biomedical perspectives. Phytochemistry 2006, 67, 1849–1855.
  6. Sutherland, B.A.; Rahman, R.M.; Appleton, I. Mechanisms of action of green tea catechins, with a focus on ischemia-induced neurodegeneration. J. Nutr. Biochem. 2006, 17, 291–306.
  7. Mereles, D.; Hunstein, W. Epigallocatechin-3-gallate (EGCG) for Clinical Trials: More Pitfalls than Promises? Int. J. Mol. Sci. 2011, 12, 5592–5603.
  8. Das, S.; Tanwar, J.; Hameed, S.; Fatima, Z. Antimicrobial potential of epigallocatechin-3-gallate (EGCG): A green tea polyphenol. J. Biochem. Pharmacol. Res. 2014, 2, 167–174.
  9. Wink, M. Functions and Biotechnology of Plant Secondary Metabolites, 2nd ed.; Wiley-Blackwell: Chichester, UK, 2010; p. xiii.
  10. Cechinel-Filho, V. Plant Bioactives and Drug Discovery: Principles, Practice, and Perspectives; John Wiley & Sons: Hoboken, NJ, USA, 2012; p. vii.
  11. Grotewold, E. The Science of Flavonoids; Springer: New York, NY, USA, 2008; p. vii.
  12. Fraga, C.G. Plant Phenolics and Human Health: Biochemistry, Nutrition, and Pharmacology; Wiley: Hoboken, NJ, USA, 2010.
  13. Khan, N.; Afaq, F.; Saleem, M.; Ahmad, N.; Mukhtar, H. Targeting Multiple Signaling Pathways by Green Tea Polyphenol (−)-Epigallocatechin-3-Gallate. Cancer Res. 2006, 66, 2500–2505.
  14. Botten, D.; Fugallo, G.; Fraternali, F.; Molteni, C. Structural Properties of Green Tea Catechins. J. Phys. Chem. B 2015, 119, 12860–12867.
  15. James, K.; Whitesell, B. An Encyclopedia of Chemicals, Drugs & Biologicals, 5nd ed.; Chapman & Hall: New York, NY, USA, 1997.
  16. Istenič, K.; Korošec, R.C.; Ulrih, N.P. Encapsulation of (−)-epigallocatechin gallate into liposomes and into alginate or chitosan microparticles reinforced with liposomes. J. Sci. Food Agric. 2016, 96, 4623–4632.
  17. Li, N.; Taylor, L.S.; Ferruzzi, M.G.; Mauer, L.J. Kinetic Study of Catechin Stability: Effects of pH, Concentration, and Temperature. J. Agric. Food Chem. 2012, 60, 12531–12539.
  18. Puligundla, P.; Mok, C.; Ko, S.; Liang, J.; Recharla, N. Nanotechnological approaches to enhance the bioavailability and therapeutic efficacy of green tea polyphenols. J. Funct. Foods 2017, 34, 139–151.
  19. Zhong, Y.; Shahidi, F. Lipophilized Epigallocatechin Gallate (EGCG) Derivatives as Novel Antioxidants. J. Agric. Food Chem. 2011, 59, 6526–6533.
  20. Bhushani, J.A.; Karthik, P.; Anandharamakrishnan, C. Nanoemulsion based delivery system for improved bioaccessibility and Caco-2 cell monolayer permeability of green tea catechins. Food Hydrocoll. 2016, 56, 372–382.
  21. Du, L.-L.; Fu, Q.-Y.; Xiang, L.-P.; Zheng, X.-Q.; Lu, J.-L.; Ye, J.-H.; Li, Q.-S.; Polito, C.A.; Liang, Y.-R. Tea Polysaccharides and Their Bioactivities. Molecules 2016, 21, 1449.
  22. Liang, R.; Chen, L.; Yokoyama, W.; Williams, P.A.; Zhong, F. Niosomes Consisting of Tween-60 and Cholesterol Improve the Chemical Stability and Antioxidant Activity of (−)-Epigallocatechin Gallate under Intestinal Tract Conditions. J. Agric. Food Chem. 2016, 64, 9180–9188.
  23. Paximada, P.; Echegoyen, Y.; Koutinas, A.A.; Mandala, I.G.; Lagaron, J.M. Encapsulation of hydrophilic and lipophilized catechin into nanoparticles through emulsion electrospraying. Food Hydrocoll. 2017, 64, 123–132.
  24. Wang, X.; Xie, Y.; Ge, H.; Chen, L.; Wang, J.; Zhang, S.; Guo, Y.; Li, Z.; Feng, X. Physical properties and antioxidant capacity of chitosan/epigallocatechin-3-gallate films reinforced with nano-bacterial cellulose. Carbohydr. Polym. 2018, 179, 207–220.
  25. Zhong, Y.; Ma, C.-M.; Shahidi, F. Antioxidant and antiviral activities of lipophilic epigallocatechin gallate (EGCG) derivatives. J. Funct. Foods 2012, 4, 87–93.
  26. Zhu, Q.Y.; Zhang, A.; Tsang, D.; Huang, Y.; Chen, Z.-Y. Stability of Green Tea Catechins. J. Agric. Food Chem. 1997, 45, 4624–4628.
  27. Wang, R.; Zhou, W.; Wen, R.-A.H. Kinetic Study of the Thermal Stability of Tea Catechins in Aqueous Systems Using a Microwave Reactor. J. Agric. Food Chem. 2006, 54, 5924–5932.
  28. Zeng, L.M.J.; Li, C.; Luo, L.Y. Stability of tea polyphenols solution with different pH at different temperatures. Int. J. Food Prop. 2017, 20, 1–18.
  29. Fan, F.-Y.; Shi, M.; Nie, Y.; Zhao, Y.; Ye, J.-H.; Liang, Y.-R. Differential behaviors of tea catechins under thermal processing: Formation of non-enzymatic oligomers. Food Chem. 2016, 196, 347–354.
  30. Sang, S.; Lee, M.-J.; Hou, Z.; Ho, C.-T.; Yang, C.S. Stability of Tea Polyphenol (−)-Epigallocatechin-3-gallate and Formation of Dimers and Epimers under Common Experimental Conditions. J. Agric. Food Chem. 2005, 53, 9478–9484.
  31. Krupkova, O.; Ferguson, S.J.; Wuertz-Kozak, K. Stability of (−)-epigallocatechin gallate and its activity in liquid formulations and delivery systems. J. Nutr. Biochem. 2016, 37, 1–12.
  32. Wang, R.; Zhou, W.; Jiang, X. Reaction Kinetics of Degradation and Epimerization of Epigallocatechin Gallate (EGCG) in Aqueous System over a Wide Temperature Range. J. Agric. Food Chem. 2008, 56, 2694–2701.
  33. Suzuki, M.; Sano, M.; Yoshida, R.; Degawa, M.; Miyase, T.; Maeda-Yamamoto, M. Epimerization of Tea Catechins and O-Methylated Derivatives of (−)-Epigallocatechin-3-O-gallate: Relationship between Epimerization and Chemical Structure. J. Agric. Food Chem. 2003, 51, 510–514.
  34. Cai, Y.; Zhang, J.; Chen, N.G.; Shi, Z.; Qiu, J.; He, C.; Chen, M. Recent advances in anticancer activities and drug delivery systems of tannins. Med. Res. Rev. 2017, 37, 665–701.
  35. Thangapandiyan, S.; Miltonprabu, S. Epigallocatechin gallate effectively ameliorates fluoride-induced oxidative stress and DNA damage in the liver of rats. Can. J. Physiol. Pharmacol. 2013, 91, 528–537.
  36. Wei, R.; Mao, L.; Xu, P.; Zheng, X.; Hackman, R.M.; MacKenzie, G.G.; Wang, Y. Suppressing glucose metabolism with epigallocatechin-3-gallate (EGCG) reduces breast cancer cell growth in preclinical models. Food Funct. 2018, 9, 5682–5696.
  37. Shang, W.; Lu, W.; Han, M.; Qiao, J. The interactions of anticancer agents with tea catechins: Current evidence from preclinical studies. Anti-Cancer Agents Med. Chem. 2014, 14, 1343–1350.
  38. Lecumberri, E.; Dupertuis, Y.M.; Miralbell, R.; Pichard, C. Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy. Clin. Nutr. 2013, 32, 894–903.
  39. Pal, S.; Dey, S.K.; Saha, C. Inhibition of Catalase by Tea Catechins in Free and Cellular State: A Biophysical Approach. PLoS ONE 2014, 9, e102460.
  40. Singh, B.N.; Shankar, S.; Srivastava, R.K. Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications. Biochem. Pharmacol. 2011, 82, 1807–1821.
  41. Ross, S.A. Evidence for the relationship between diet and cancer. Exp. Oncol. 2010, 32, 137–142.
  42. Wu, F.; Sun, H.; Kluz, T.; Clancy, H.A.; Kiok, K.; Costa, M. Epigallocatechin-3-gallate (EGCG) protects against chromate-induced toxicity in vitro. Toxicol. Appl. Pharmacol. 2012, 258, 166–175.
  43. Cabrera, C.; Artacho, R.; Giménez, R. Beneficial Effects of Green Tea—A Review. J. Am. Coll. Nutr. 2006, 25, 79–99.
  44. Lee, B.-L.; Ong, C.-N. Comparative analysis of tea catechins and theaflavins by high-performance liquid chromatography and capillary electrophoresis. J. Chromatogr. A 2000, 881, 439–447.
  45. De Pascual-Teresa, S.; Santos-Buelga, C.; Rivas-Gonzalo, J.C. Quantitative analysis of flavan-3-ols in Spanish foodstuffs and beverages. J. Agric. Food Chem. 2000, 48, 5331–5337.
  46. Shishikura, Y.; Khokhar, S. Factors affecting the levels of catechins and caffeine in tea beverage: Estimated daily intakes and antioxidant activity. J. Sci. Food Agric. 2005, 85, 2125–2133.
  47. Rusak, G.; Komes, D.; Likić, S.; Horžić, D.; Kovač, M. Phenolic content and antioxidative capacity of green and white tea extracts depending on extraction conditions and the solvent used. Food Chem. 2008, 110, 852–858.
  48. Reto, M.; Figueira, M.E.; Filipe, H.M.; Almeida, C.M.M. Chemical Composition of Green Tea (Camellia sinensis) Infusions Commercialized in Portugal. Plant Foods Hum. Nutr. 2007, 62, 139–144.
  49. Rechner, A.; Wagner, E.; Van Buren, L.; Van De Put, F.; Wiseman, S.; Rice-Evans, C. Black tea represents a major source of dietary phenolics among regular tea drinkers. Free Radic. Res. 2002, 36, 1127–1135.
  50. Bhagwat, S.; Haytowitz, D.B.; Holden, J.M. USDA Database for the Flavonoid Content of Selected Foods; US Department of Agriculture: Beltsville, MD, USA, 2011.
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to :
View Times: 502
Revisions: 2 times (View History)
Update Date: 11 Nov 2021